758
E. C. Swift et al.
Cluster
Synlett
hedron Lett. 2004, 45, 6587. (f) Guadarrama-Morales, O.;
Méndez, F.; Miranda, L. D. Tetrahedron Lett. 2007, 48, 4515.
(g) Lindsay, K. B.; Ferrando, F.; Christensen, K. L.; Overgaard, J.;
Roca, T.; Bennasar, M.; Skrydstrup, T. J. Org. Chem. 2007, 72,
4181. (h) Reyes-Gutiérrez, P. E.; Torres-Ochoa, R. O.; Martínez,
R.; Miranda, L. D. Org. Biomol. Chem. 2009, 7, 1388.
rounded by a string of 1 W blue LEDs and stirred under N2 at r.t.
for 24 h. The resulting mixture was diluted with EtOAc and
extracted with H2O. The aqueous layer was extracted with
EtOAc (2 × 5 mL). The combined organic layers were washed
with brine, dried (Na2SO4), and concentrated in vacuo. The
residue was purified by chromatography (silica gel, 0–5%
EtOAc–hexane) to give a white solid; yield: 97 mg (83%);
Rf = 0.36 (10% EtOAc–hexane). IR (neat): 3372, 2972, 1732,
1707, 1454, 1263 cm–1. 1H NMR (400 MHz, CDCl3): δ = 9.08 (s, 1
H), 7.58 (d, J = 7.9 Hz, 1 H), 7.37 (d, J = 7.6 Hz, 1 H), 7.18 (t, J = 7.1
Hz, 1 H), 7.09 (t, J = 7.1 Hz, 1 H), 6.47 (s, 1 H), 4.27–4.23 (m, 4 H),
1.95 (s, 3 H), 1.28 (t, J = 7.1 Hz, 6 H). 13C NMR (176 MHz, CDCl3):
δ = 170.4, 136.2, 134.7, 127.5, 122.2, 120.5, 119.7, 111.0, 101.4,
62.2, 54.3, 21.2, 14.0. HRMS (ESI): m/z [M + H]+ calcd for C16H20NO4:
290.1387; found: 290.1386.
(9) (a) Furst, L.; Matsuura, B. S.; Narayanam, J. M. R.; Tucker, J. W.;
Stephenson, C. R. J. Org. Lett. 2010, 12, 3104. (b) Tucker, J. W.;
Narayanam, J. M. R.; Krabbe, S. W.; Stephenson, C. R. J. Org. Lett.
2010, 12, 368.
(10) (a) Kaburagi, Y.; Tokuyama, H.; Fukuyama, T. J. Am. Chem. Soc.
2004, 126, 10246. (b) Martin, C. L.; Overman, L. E.; Rohde, J. M.
J. Am. Chem. Soc. 2010, 132, 4894. (c) Martin, C. L.; Nakamura,
S.; Otte, R.; Overman, L. E. Org. Lett. 2011, 13, 138. (d) Kuehne,
M. E.; Roland, D. M.; Hafter, R. J. Org. Chem. 1978, 43, 3705.
(e) Magolan, J.; Kerr, M. A. Org. Lett. 2006, 8, 4561.
(11) For selected recent examples of malonates in the synthesis of
pharmaceutically relevant molecules, see: (a) Yamakawa, N.;
Suemasu, S.; Okamoto, Y.; Tanaka, K.-i.; Ishihara, T.; Asano, T.;
Miyata, K.; Otsuka, M.; Mizushima, T. J. Med. Chem. 2012, 55,
5143. (b) Roth, G. J.; Heckel, A.; Colbatzky, F.; Handschuh, S.;
Kley, J.; Lehmann-Lintz, T.; Lotz, R.; Tontsch-Grunt, U.; Walter,
R.; Hilberg, F. J. Med. Chem. 2009, 52, 4466. (c) Duan, J. J.-W.;
Chen, L.; Lu, Z.; Jiang, B.; Asakawa, N.; Sheppeck, J. E. II.; Liu, R.-
Q.; Covington, M. B.; Pitts, W.; Kim, S.-H.; Decicco, C. P. Bioorg.
Med. Chem. Lett. 2007, 17, 266.
Dimethyl (4-{[tert-Butyl(dimethyl)silyl]oxy}butyl)(1H-indol-
2-yl)malonate (14)
Yellow oil; yield: 0.15 g (89%); Rf = 0.6 (20% EtOAc–hexane). IR
1
(neat): 3426, 2951, 2356, 1729, 1456, 1254 cm–1. H NMR (700
MHz, CDCl3): δ = 9.60 (s, 1 H), 7.58 (d, J = 7.9 Hz, 1 H), 7.40 (d, J =
8.1 Hz, 1 H), 7.20 (t, J = 7.6 Hz, 1 H), 7.11 (t, J = 7.5 Hz, 1 H), 6.44
(s, 1 H), 3.78 (s, 6 H), 3.57 (t, J = 6.3 Hz, 2 H), 2.45–2.43 (m, 2 H),
1.54 (quintet, J = 7.1 Hz, 2 H), 1.29–1.25 (m, 2 H), 0.87 (s, 9 H),
0.02 (s, 6 H). 13C NMR (176 MHz, CDCl3): δ = 170.6, 135.8, 133.9,
127.7, 122.1, 120.5, 119.9, 111.3, 101.3, 62.6, 58.5, 53.2, 36.5,
32.8, 26.0, 21.1, 18.3, –5.2. HRMS (ESI): m/z [M + H]+ calcd for
(12) Mahboobi, S.; Kuhr, S.; Meindl, W. Arch. Pharm. (Weinheim, Ger.)
1994, 327, 611.
C23H36NO5Si: 434.2357; found: 434.2355.
Methyl 3-(1H-Indol-2-yl)-2-oxooxepane-3-carboxylate (24)
Purple oil; yield: 40 mg (35%); Rf = 0.25 (30% EtOAc–hexane). IR
(neat): 3317, 2943, 2360, 1738, 1696, 1454, 1224 cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.72 (s, 1 H), 7.59 (d, J = 7.9 Hz, 1 H), 7.38
(dd, J = 8.2, 0.7 Hz, 1 H), 7.20 (td, J = 7.6, 1.1 Hz, 1 H), 7.11 (td, J =
7.5, 0.8 Hz, 1 H), 6.50 (d, J = 1.3 Hz, 1 H), 4.19 (ddd, J = 12.7, 7.6,
1.9 Hz, 1 H), 4.08 (ddd, J = 12.7, 8.1, 1.8 Hz, 1 H), 3.78 (s, 3 H),
2.72 (dt, J = 14.7, 5.8 Hz, 1 H), 2.38 (dt, J = 14.7, 6.6 Hz, 1 H), 2.06
(quintet, J = 6.1 Hz, 2 H), 1.94–1.88 (m, 1 H), 1.85–1.80 (m, 1 H).
13C NMR (176 MHz, CDCl3): δ = 171.6, 169.6, 136.7, 133.6, 127.7,
122.8, 120.8, 120.2, 111.4, 102.3, 69.5, 59.8, 53.5, 31.3, 28.1,
24.1. HRMS (ESI): m/z [M + H]+ calcd for C16H18NO4: 288.1230;
found: 288.1299.
(13) (a) Beyer, J.; Jensen, B. S.; Strøbaek, D.; Christophersen, P.;
Teuber, L. WO 037422, 2000. (b) Ledoux, J.; Werner, M. E.;
Brayden, J. E.; Nelson, M. T. Physiology (Bethesda) 2006, 21, 69.
(c) Dolga, A. M.; Culmsee, C. Front. Pharmacol. 2012, 3, 196.
(14) Devery, J. J. III.; Douglas, J. J.; Nguyen, J. D.; Cole, K. P.; Flowers, R.
A. II.; Stephenson, C. R. J. Chem. Sci. 2015, 6, 537.
(15) (a) Kalyanasundaram, K. Coord. Chem. Rev. 1982, 46, 159.
(b) Juris, A.; Balzani, V.; Belser, P.; von Zelewsky, A. Helv. Chim.
Acta 1981, 64, 2175.
(16) Lowry, M. S.; Goldsmith, J. I.; Slinker, J. D.; Rohl, R.; Pascal, R. A.;
Malliaras, G. G.; Bernhard, S. Chem. Mater. 2005, 17, 5712.
(17) Slinker, J. D.; Gorodetsky, A. A.; Lowry, M. S.; Wang, J.; Parker, S.;
Rohl, R.; Bernhard, S.; Malliaras, G. G. J. Am. Chem. Soc. 2004,
126, 2763.
Diethyl
Methyl(1-methyl-2-oxo-1,2-dihydropyridin-3-
yl)malonate (29)
(18) Flamigni, L.; Barbieri, A.; Sabatini, C.; Ventura, B.; Barigelletti, F.
Top. Curr. Chem. 2007, 281, 143.
Brown oil; yield: 0.11 g (80%); Rf = 0.5 (20% EtOAc–hexane). IR
1
(neat): 2982, 1724, 1648, 1597, 1558, 1228 cm–1. H NMR (400
(19) The reaction was found to proceed in a number of solvents; see
Supporting Information for details.
(20) Nguyen, J. D.; D’Amato, E. M.; Narayanam, J. M. R.; Stephenson,
C. R. J. Nat. Chem. 2012, 4, 854.
(21) Nguyen, J. D.; Tucker, J. W. Konieczynska M. D.; Stephenson, C. R.
J. J. Am. Chem. Soc. 2011, 133, 4160.
(22) Fors, B. P.; Hawker, C. J. Angew. Chem. Int. Ed. 2012, 51, 8850.
(23) Diethyl 1H-Indol-2-yl(methyl)malonate (7); Typical Proce-
dure
MHz, CDCl3): δ = 7.24–7.21 (m, 2 H), 6.08 (t, J = 6.9 Hz, 1 H),
4.24–4.13 (m, 4 H), 3.47 (s, 3 H), 1.74 (s, 3 H), 1.20 (t, J = 7.1 Hz,
6 H). 13C NMR (176 MHz, CDCl3): δ = 170.7, 161.2, 137.5, 135.4,
131.7, 105.0, 61.6, 57.4, 37.8, 20.8, 14.0. HRMS (ESI): m/z [M +
Na]+ calcd for C14H19NNaO5: 304.1155; found: 304.1155.
(24) Smith, F. X.; Evans, G. G. Tetrahedron Lett. 1972, 13, 1237.
(25) (a) For a recent review, see: Su, Y.; Straathof, N. J. W.; Hessel, V.;
Noël, T. Chem. Eur. J. 2014, 20, 10562. For selected examples, see.
(b) Bou-Hamdan, F. R.; Seeberger, P. H. Chem. Sci. 2012, 3, 1612.
(c) Andrews, R. S.; Becker, J. J.; Gagné, M. R. Angew. Chem. Int. Ed.
2012, 51, 4140. (d) Tucker, J. W.; Zhang, Y.; Jamison, T. F.;
Stephenson, C. R. J. Angew. Chem. Int. Ed. 2012, 51, 4144.
(e) Beatty, J.; Stephenson, C. R. J. J. Am. Chem. Soc. 2014, 136,
10270.
A 7 mL vial equipped with magnetic stirrer bar was charged
with diethyl-2-bromo-2-methylmalonate (1.0 equiv, 0.40
mmol, 0.10g), 2,6-lutidine (1.0 equiv, 0.40 mmol, 43 mg),
Ir(ppy)3 (1 mol%, 4.0 μmol, 2.6 mg), and indole (5.0 equiv, 2.0
mmol, 0.23 g). Anhyd MeCN (0.5 mL, 0.8 M) was added, and the
mixture was sparged with N2 for 15 min. It was then sur-
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, 754–758